BioPharmGuy logo
Sponsored By:
Trianni Inc.
Weekly Update Subscription
Emery Pharma
Cellective Therapeutics is defunct.

Fate: Acquired by MedImmune 2005, Up to $175M


------------------
If you believe any of this information is incorrect, please let us know.